XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway-Reference-Cited by-同舟云学术

XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway

Published:2014-03-23 Issue:7494 Volume:508 Page:103-107
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Chen Xi,Iliopoulos Dimitrios,Zhang Qing,Tang Qianzi,Greenblatt Matthew B.,Hatziapostolou Maria,Lim Elgene,Tam Wai Leong,Ni Min,Chen Yiwen,Mai Junhua,Shen Haifa,Hu Dorothy Z.,Adoro Stanley,Hu Bella,Song Minkyung,Tan Chen,Landis Melissa D.,Ferrari Mauro,Shin Sandra J.,Brown Myles,Chang Jenny C.,Liu X. Shirley,Glimcher Laurie H.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature13119.pdf

Reference30 articles.

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011)

2. Walter, P. & Ron, D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 334, 1081–1086 (2011)

3. Yoshida, H., Matsui, T., Yamamoto, A., Okada, T. & Mori, K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107, 881–891 (2001)

4. Carrasco, D. R. et al. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis. Cancer Cell 11, 349–360 (2007)

5. De Raedt, T. et al. Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell 20, 400–413 (2011)

Cited by 675 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidation of the role of XBP1 in the progression of complete hydatidiform mole to invasive mole through RNA-seq;Gynecologic Oncology;2024-11

2. IRE1α‐XBP1s axis regulates SREBP1‐dependent MRP1 expression to promote chemoresistance in non‐small cell lung cancer cells;Thoracic Cancer;2024-09-08

3. Research trends on nanomaterials in triple negative breast cancer (TNBC): a bibliometric analysis from 2010 to 2024;Drug Delivery and Translational Research;2024-09-06

4. Targeted polymer lipid hybrid nanoparticles for in-vitro siRNA therapy in triple-negative breast cancer;Journal of Drug Delivery Science and Technology;2024-09

5. Metabolic regulation of mRNA splicing;Trends in Cell Biology;2024-09